CEFTRIAXONE (ROCEPHIN)

Course overview

CefTRIAXone is U.S. FDA-approved to treat moderate/severe infections caused by susceptible bacteria. It must be used cautiously in patients with a hypersensitivity to penicillins, those at risk for bleeding, or those with a history of GI disease, malnutrition, renal impairment/failure, or history of seizures. This continuing education module is designed to give the reader/learner an increased understanding of cefTRIAXone. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.